Literature DB >> 27414264

Structural Polymorphism of Alzheimer's β-Amyloid Fibrils as Controlled by an E22 Switch: A Solid-State NMR Study.

Matthew R Elkins1, Tuo Wang1, Mimi Nick2, Hyunil Jo2, Thomas Lemmin2, Stanley B Prusiner3, William F DeGrado2, Jan Stöhr3, Mei Hong1.   

Abstract

The amyloid-β (Aβ) peptide of Alzheimer's disease (n class="Disease">AD) forms polymorphic fibrils on the micrometer and molecular scales. Various fibril growth conditions have been identified to cause polymorphism, but the intrinsic amino acid sequence basis for this polymorphism has been unclear. Several single-site mutations in the center of the Aβ sequence cause different disease phenotypes and fibrillization properties. The E22G (Arctic) mutant is found in familial AD and forms protofibrils more rapidly than wild-type Aβ. Here, we use solid-state NMR spectroscopy to investigate the structure, dynamics, hydration and morphology of Arctic E22G Aβ40 fibrils. (13)C, (15)N-labeled synthetic E22G Aβ40 peptides are studied and compared with wild-type and Osaka E22Δ Aβ40 fibrils. Under the same fibrillization conditions, Arctic Aβ40 exhibits a high degree of polymorphism, showing at least four sets of NMR chemical shifts for various residues, while the Osaka and wild-type Aβ40 fibrils show a single or a predominant set of chemical shifts. Thus, structural polymorphism is intrinsic to the Arctic E22G Aβ40 sequence. Chemical shifts and inter-residue contacts obtained from 2D correlation spectra indicate that one of the major Arctic conformers has surprisingly high structural similarity with wild-type Aβ42. (13)C-(1)H dipolar order parameters, (1)H rotating-frame spin-lattice relaxation times and water-to-protein spin diffusion experiments reveal substantial differences in the dynamics and hydration of Arctic, Osaka and wild-type Aβ40 fibrils. Together, these results strongly suggest that electrostatic interactions in the center of the Aβ peptide sequence play a crucial role in the three-dimensional fold of the fibrils, and by inference, fibril-induced neuronal toxicity and AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27414264      PMCID: PMC5149419          DOI: 10.1021/jacs.6b03715

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  74 in total

1.  Determination of multiple ***φ***-torsion angles in proteins by selective and extensive (13)C labeling and two-dimensional solid-state NMR.

Authors:  M Hong
Journal:  J Magn Reson       Date:  1999-08       Impact factor: 2.229

2.  Conformational disorder of membrane peptides investigated from solid-state NMR line widths and line shapes.

Authors:  Yongchao Su; Mei Hong
Journal:  J Phys Chem B       Date:  2011-08-18       Impact factor: 2.991

Review 3.  Solid-state NMR studies of amyloid fibril structure.

Authors:  Robert Tycko
Journal:  Annu Rev Phys Chem       Date:  2011       Impact factor: 12.703

4.  Effects of amantadine on the dynamics of membrane-bound influenza A M2 transmembrane peptide studied by NMR relaxation.

Authors:  Sarah D Cady; Mei Hong
Journal:  J Biomol NMR       Date:  2009-07-25       Impact factor: 2.835

5.  Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.

Authors:  Vicki Betts; Malcolm A Leissring; Georgia Dolios; Rong Wang; Dennis J Selkoe; Dominic M Walsh
Journal:  Neurobiol Dis       Date:  2008-06-17       Impact factor: 5.996

6.  Amyloidosis of Alzheimer's Abeta peptides: solid-state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies.

Authors:  Oleg N Antzutkin
Journal:  Magn Reson Chem       Date:  2004-02       Impact factor: 2.447

7.  Probing membrane protein structure using water polarization transfer solid-state NMR.

Authors:  Jonathan K Williams; Mei Hong
Journal:  J Magn Reson       Date:  2014-08-25       Impact factor: 2.229

8.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Authors:  Chester A Mathis; Yanming Wang; Daniel P Holt; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

9.  Atomic-resolution three-dimensional structure of amyloid β fibrils bearing the Osaka mutation.

Authors:  Anne K Schütz; Toni Vagt; Matthias Huber; Oxana Y Ovchinnikova; Riccardo Cadalbert; Joseph Wall; Peter Güntert; Anja Böckmann; Rudi Glockshuber; Beat H Meier
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-13       Impact factor: 15.336

10.  Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein.

Authors:  Marcus D Tuttle; Gemma Comellas; Andrew J Nieuwkoop; Dustin J Covell; Deborah A Berthold; Kathryn D Kloepper; Joseph M Courtney; Jae K Kim; Alexander M Barclay; Amy Kendall; William Wan; Gerald Stubbs; Charles D Schwieters; Virginia M Y Lee; Julia M George; Chad M Rienstra
Journal:  Nat Struct Mol Biol       Date:  2016-03-28       Impact factor: 15.369

View more
  30 in total

1.  A long-lived Aβ oligomer resistant to fibrillization.

Authors:  Mimi Nick; Yibing Wu; Nathan W Schmidt; Stanley B Prusiner; Jan Stöhr; William F DeGrado
Journal:  Biopolymers       Date:  2018-01-10       Impact factor: 2.505

2.  Water Distribution, Dynamics, and Interactions with Alzheimer's β-Amyloid Fibrils Investigated by Solid-State NMR.

Authors:  Tuo Wang; Hyunil Jo; William F DeGrado; Mei Hong
Journal:  J Am Chem Soc       Date:  2017-04-21       Impact factor: 15.419

3.  Coexisting order and disorder within a common 40-residue amyloid-β fibril structure in Alzheimer's disease brain tissue.

Authors:  Ujjayini Ghosh; Wai-Ming Yau; Robert Tycko
Journal:  Chem Commun (Camb)       Date:  2018-05-15       Impact factor: 6.222

4.  Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide.

Authors:  Asa Hatami; Sanaz Monjazeb; Saskia Milton; Charles G Glabe
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

5.  Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β.

Authors:  Kyle J Korshavn; Cristina Satriano; Yuxi Lin; Rongchun Zhang; Mark Dulchavsky; Anirban Bhunia; Magdalena I Ivanova; Young-Ho Lee; Carmelo La Rosa; Mi Hee Lim; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

6.  In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments.

Authors:  Aurelio J Dregni; Venkata S Mandala; Haifan Wu; Matthew R Elkins; Harrison K Wang; Ivan Hung; William F DeGrado; Mei Hong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

7.  Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.

Authors:  Atsushi Aoyagi; Carlo Condello; Jan Stöhr; Weizhou Yue; Brianna M Rivera; Joanne C Lee; Amanda L Woerman; Glenda Halliday; Sjoerd van Duinen; Martin Ingelsson; Lars Lannfelt; Caroline Graff; Thomas D Bird; C Dirk Keene; William W Seeley; William F DeGrado; Stanley B Prusiner
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

8.  Fast Motions of Key Methyl Groups in Amyloid-β Fibrils.

Authors:  Liliya Vugmeyster; Dmitry Ostrovsky; Matthew A Clark; Isaac B Falconer; Gina L Hoatson; Wei Qiang
Journal:  Biophys J       Date:  2016-11-15       Impact factor: 4.033

9.  3D MAS NMR Experiment Utilizing Through-Space 15N-15N Correlations.

Authors:  Kevin J Donovan; Robert Silvers; Sara Linse; Robert G Griffin
Journal:  J Am Chem Soc       Date:  2017-05-03       Impact factor: 15.419

10.  Zinc-binding structure of a catalytic amyloid from solid-state NMR.

Authors:  Myungwoon Lee; Tuo Wang; Olga V Makhlynets; Yibing Wu; Nicholas F Polizzi; Haifan Wu; Pallavi M Gosavi; Jan Stöhr; Ivan V Korendovych; William F DeGrado; Mei Hong
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.